| Butyrate esterified to starch is released in the human gastrointestinal tract. | |
| | |
MedLine Citation:
|
PMID: 21940597 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Short-chain fatty acids (SCFAs) maintain human colonic function and may help prevent colonic disease. A study with ileostomists showed that starches acylated with specific SCFAs largely survive passage through the small intestine, but the percentage released in the colon has not been established. OBJECTIVE: The objective was to determine the percentage of ingested esterified butyrate released in the human gastrointestinal tract. DESIGN: The study was a randomized, crossover, controlled trial consisting of baseline and four 2-wk periods during which 16 volunteers consumed diets low in resistant starch plus 20 and 40 g cooked high-amylose maize starch (HAMS: HAMS20 or HAMS40) or butyrylated HAMS (HAMSB20 or HAMSB40) daily. HAMSB20 contained 31.8 mmol esterified butyrate. Complete 48-h fecal collections were made on days 2-3 and 12-13 of each period. RESULTS: Free fecal butyrate concentrations were higher after HAMSB40 than after HAMSB20 (P < 0.005) and HAMS (P < 0.0001) and higher than baseline data (P < 0.0001). Fecal esterified butyrate concentrations were highest in the HAMSB40 (days 12-13; P < 0.0001) group, and concentrations in the HAMSB40 (days 2-3) and HAMSB20 groups were higher than those in the HAMS groups and those at baseline (P < 0.0001). Ingestion of HAMSB20 and HAMSB40 resulted in the release of 26.8 ± 1.0 and 50.2 ± 2.4 mmol butyrate/d (days 12-13) (84.2 ± 3.0% and 79.0 ± 3.1% of total ingested esterified butyrate), respectively, in the gastrointestinal tract. By calculation, ∼57.2% of ingested esterified butyrate was released in the colon. Microbial analysis showed that this release was probably facilitated mainly by Parabacteroides distasonis, which increased in abundance with HAMSB40 (days 12-13) (P < 0.001). CONCLUSIONS: This study shows that cooked butyrylated starch delivers esterified butyrate to the human colon effectively and has the potential to improve human bowel health. This trial is registered in the Australian Clinical Trials Registry as ACTRN012606000398505. |
| | |
Authors:
|
Julie M Clarke; David L Topping; Claus T Christophersen; Anthony R Bird; Kylie Lange; Ian Saunders; Lynne Cobiac |
Related Documents
:
|
12508087 - A placebo-controlled comparison of effects of repetitive doses of betamethasone and dex... 8277517 - Cadmium-109 metabolism in mice. iv. diet versus maternal stores as a source of cadmium ... 21363937 - The pparβ/δ activator gw501516 prevents the down-regulation of ampk caused by a high-... 16202717 - Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregn... 8374247 - Gastric emptying of solids and liquids in obesity. 2743167 - Zinc, copper and iron utilisation by chicks fed various concentrations of zinc. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-21 |
Journal Detail:
|
Title: The American journal of clinical nutrition Volume: - ISSN: 1938-3207 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0376027 Medline TA: Am J Clin Nutr Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Preventative Health National Research Flagship, Commonwealth Scientific and Industrial Research Organisation, Food and Nutritional Sciences, Adelaide, South Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diet and bone mineral density study in postmenopausal women from the TwinsUK registry shows a negati...
Next Document: Effects of a 2-y dietary weight-loss intervention on cholesterol metabolism in moderately obese men.